The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment

References

• RodriguesFFSantosREMeloMBCorrelation of polymorphism C3435T of the MDR-1 gene and the response of primary chemotherapy in women with locally advanced breast cancerGenet Mol Res20087117718318393221
   PubMed Web of Science ®Google Scholar
• MizunoNSugiyamaYDrug transporters: their role and importance in the selection and development of new drugsDrug Metab Pharmacokinet20021729310815618657
   PubMedGoogle Scholar
• EvansWEMcLeodHLPharmacogenomics – drug disposition, drug targets, and side effectsN Engl J Med2003348653854912571262
   PubMed Web of Science ®Google Scholar
• StearnsVDavidsonNEFlockhartDAPharmacogenetics in the treatment of breast cancerPharmacogenomics J20044314315315024382
   PubMed Web of Science ®Google Scholar
• ZinziLCapparelliECantoreMContinoMLeopoldoMColabufoNASmall and innovative molecules as new strategy to revert MDRFront Oncol20144224478983
   PubMedGoogle Scholar
• BurgerHFoekensJALookMPRNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic responseClin Cancer Res20039282783612576456
   PubMed Web of Science ®Google Scholar
• MutohKTsukaharaSMitsuhashiJKatayamaKSugimotoYEstrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cellsCancer Sci200697111198120416925584
   PubMed Web of Science ®Google Scholar
• GeorgeJDharanipragadaKKrishnamachariSChandrasekaranASamSSSunderEA single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancerClin Breast Cancer20099316116519661039
   PubMed Web of Science ®Google Scholar
• ZhangBLSunTZhangBNPolymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancerChin Med J (Engl)2011124219920421362365
   PubMed Web of Science ®Google Scholar
• ChaturvediPTulsyanSAgarwalGInfluence of ABCB1 genetic variants in breast cancer treatment outcomesCancer Epidemiol201337575476123707158
   PubMed Web of Science ®Google Scholar
• TulsyanSChaturvediPSinghAKAssessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approachGene20145431697524704000
   PubMed Web of Science ®Google Scholar
• BrayJSluddenJGriffinMJInfluence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamideBr J Cancer201010261003100920179710
   PubMed Web of Science ®Google Scholar
• VaclavikovaREhrlichovaMHlavataIDetection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosisClin Chem Lab Med201250111999200723093106
   PubMed Web of Science ®Google Scholar
• TsaiSMLinCYWuSHSide effects after docetaxel treatment in Taiwanese breast cancer patients with CYP3A4, CYP3A5, and ABCB1 gene polymorphismsClin Chim Acta2009404216016519332043
   PubMed Web of Science ®Google Scholar
• JiMTangJZhaoJXuBQinJLuJPolymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patientsCancer Biol Ther201213526427122310978
   PubMed Web of Science ®Google Scholar
• CizmarikovaMWagnerovaMSchonovaLMDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcomePharmacogenomics J2010101626919752884
   PubMed Web of Science ®Google Scholar
• WuHKangHLiuYRoles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomesJ Cancer Res Clin Oncol201213891449146222526155
   PubMed Web of Science ®Google Scholar
• LingVMultidrug resistance: molecular mechanisms and clinical relevanceCancer Chemother Pharmacol199740supplS3S89272126
   PubMed Web of Science ®Google Scholar
• SchinkelAHJonkerJWMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overviewAdv Drug Deliv Rev200355132912535572
   PubMed Web of Science ®Google Scholar
• JulianoRLLingVA surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochim Biophys Acta19764551152162990323
   PubMed Web of Science ®Google Scholar
• UedaKClarkDPChenCJRoninsonIBGottesmanMMPastanIThe human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiationJ Biol Chem198726225055083027054
   PubMed Web of Science ®Google Scholar
• FojoALeboRShimizuNLocalization of multidrug resistance-associated DNA sequences to human chromosome 7Somat Cell Mol Genet19861244154203016920
   PubMedGoogle Scholar
• RiordanJRDeucharsKKartnerNAlonNTrentJLingVAmplification of P-glycoprotein genes in multidrug-resistant mammalian cell linesNature198531660318178192863759
   PubMed Web of Science ®Google Scholar
• BodorMKellyEJHoRJCharacterization of the human MDR1 geneAAPS J200571E1E516146331
   PubMed Web of Science ®Google Scholar
• ChenCJClarkDUedaKPastanIGottesmanMMRoninsonIBGenomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteinsJ Biol Chem199026515065141967175
   PubMed Web of Science ®Google Scholar
• AllerSGYuJWardAStructure of P-glycoprotein reveals a molecular basis for poly-specific drug bindingScience200932359221718172219325113
   PubMed Web of Science ®Google Scholar
• WardAReyesCLYuJRothCBChangGFlexibility in the ABC transporter MsbA: alternating access with a twistProc Natl Acad Sci USA200710448190051901018024585
   PubMed Web of Science ®Google Scholar
• GribarJJRamachandraMHrycynaCADeySAmbudkarSVFunctional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression systemJ Membr Biol2000173320321410667916
   PubMed Web of Science ®Google Scholar
• ZhangJTLingVStudy of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translationJ Biol Chem19912662718224182321680860
   PubMed Web of Science ®Google Scholar
• FungKLGottesmanMMA synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein functionBiochim Biophys Acta20091794586087119285158
   PubMed Web of Science ®Google Scholar
• JonesPMGeorgeAMThe ABC transporter structure and mechanism: perspectives on recent researchCell Mol Life Sci200461668269915052411
   PubMed Web of Science ®Google Scholar
• BorstPElferinkROMammalian ABC transporters in health and diseaseAnnu Rev Biochem20027153759212045106
   PubMed Web of Science ®Google Scholar
• AmbudkarSVDeySHrycynaCARamachandraMPastanIGottesmanMMBiochemical, cellular, and pharmacological aspects of the multidrug transporterAnnu Rev Pharmacol Toxicol19993936139810331089
   PubMed Web of Science ®Google Scholar
• KrishnamurthyPRossDDNakanishiTThe stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with hemeJ Biol Chem200427923242182422515044468
   PubMed Web of Science ®Google Scholar
• FreletAKleinMInsight in eukaryotic ABC transporter function by mutation analysisFEBS Lett200658041064108416442101
   PubMed Web of Science ®Google Scholar
• LooTWClarkeDMRecent progress in understanding the mechanism of P-glycoprotein-mediated drug effluxJ Membr Biol2005206317318516456713
   PubMed Web of Science ®Google Scholar
• SharomFJABC multidrug transporters: structure, function and role in chemoresistancePharmacogenomics20089110512718154452
   PubMed Web of Science ®Google Scholar
• CallaghanRFordRCKerrIDThe translocation mechanism of P-glycoproteinFEBS Lett200658041056106316380120
   PubMed Web of Science ®Google Scholar
• HigginsCFMultiple molecular mechanisms for multidrug resistance transportersNature2007446713774975717429392
   PubMed Web of Science ®Google Scholar
• SchinkelAHKempSDolleMRudenkoGWagenaarEN-glycosylation and deletion mutants of the human MDR1 P-glycoproteinJ Biol Chem199326810747474818096511
   PubMed Web of Science ®Google Scholar
• BorstPSchinkelAHSmitJJClassical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammalsPharmacol Ther19936022892997912835
   PubMed Web of Science ®Google Scholar
• Cordon-CardoCO’BrienJPBocciaJCasalsDBertinoJRMelamedMRExpression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissuesJ Histochem Cytochem1990389127712871974900
   PubMed Web of Science ®Google Scholar
• FojoATUedaKSlamonDJPoplackDGGottesmanMMPastanIExpression of a multidrug-resistance gene in human tumors and tissuesProc Natl Acad Sci U S A19878412652692432605
   PubMed Web of Science ®Google Scholar
• SugawaraIKataokaIMorishitaYTissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16Cancer Res1988487192619292894894
   PubMed Web of Science ®Google Scholar
• KwanPBrodieMJPotential role of drug transporters in the pathogenesis of medically intractable epilepsyEpilepsia200546222423515679503
   PubMed Web of Science ®Google Scholar
• GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP-dependent transportersNat Rev Cancer200221485811902585
   PubMed Web of Science ®Google Scholar
• WolfSJBachtiarMWangJSimTSChongSSLeeCGAn update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokineticsPharmacogenomics J201111531532521625253
   PubMed Web of Science ®Google Scholar
• IeiriITakaneHHirotaTOtsuboKHiguchiSGenetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapyExpert Opin Drug Metab Toxicol20062565167417014387
   PubMed Web of Science ®Google Scholar
• Human ATP-Binding Cassette Transporters [database on the Internet]Nutrition, Metabolism and Genomics Group, Wageningen UniversityThe Netherlands Available from: http://nutrigene.4t.com/humanabc.htmAccessed February 25, 2016
   Google Scholar
• HoffmeyerSBurkOvon RichterOFunctional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProc Natl Acad Sci USA20009773473347810716719
   PubMed Web of Science ®Google Scholar
• Kimchi-SarfatyCOhJMKimIWA “silent” polymorphism in the MDR1 gene changes substrate specificityScience2007315581152552817185560
   PubMed Web of Science ®Google Scholar
• CascorbiIRole of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugsPharmacol Ther2006112245747316766035
   PubMed Web of Science ®Google Scholar
• SaunaZEKimchi-SarfatyCAmbudkarSVGottesmanMMSilent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancerCancer Res200767209609961217942888
   PubMed Web of Science ®Google Scholar
• LongoRD’AndreaMSarmientoRGaspariniGPharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumabExpert Opin Investig Drugs201019suppl 1S41S50
   PubMed Web of Science ®Google Scholar
• BalramCSharmaASivathasanCLeeEJFrequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlatesBr J Clin Pharmacol2003561788312848778
   PubMed Web of Science ®Google Scholar
• TangKNgoiSMGweePCDistinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populationsPharmacogenetics200212643745012172212
   PubMedGoogle Scholar
• SensornISirachainanEChamnanphonMAssociation of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifenPharmgenomics Pers Med20136939824019753
   PubMedGoogle Scholar
• IllmerTSchulerUSThiedeCMDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patientsCancer Res200262174955496212208746
   PubMed Web of Science ®Google Scholar
• KimRBLeakeBFChooEFIdentification of functionally variant MDR1 alleles among European Americans and African AmericansClin Pharmacol Ther200170218919911503014
   PubMed Web of Science ®Google Scholar
• NakamuraTSakaedaTHorinouchiMEffect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjectsClin Pharmacol Ther200271429730311956513
   PubMed Web of Science ®Google Scholar
• BrinkmannURootsIEichelbaumMPharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapyDrug Discov Today200161683583911495756
   PubMed Web of Science ®Google Scholar
• SiegsmundMBrinkmannUSchaffelerEAssociation of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumorsJ Am Soc Nephrol20021371847185412089380
   PubMed Web of Science ®Google Scholar
• WangDJohnsonADPappACKroetzDLSadéeWMultidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stabilityPharmacogenet Genomics2005151069370416141795
   PubMed Web of Science ®Google Scholar
• HitzlMDrescherSvan der KuipHThe C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cellsPharmacogenetics200111429329811434506
   PubMedGoogle Scholar
• HungCCChenCCLinCJLiouHHFunctional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugsPharmacogenet Genomics200818539040218408562
   PubMed Web of Science ®Google Scholar
• LevranOO’HaraKPelesEABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependenceHum Mol Genet200817142219222718424454
   PubMed Web of Science ®Google Scholar
• TanabeMIeiriINagataNExpression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 geneJ Pharmacol Exp Ther200129731137114311356939
   PubMed Web of Science ®Google Scholar
• YamashitaMNakamuraTChoDYLeeJDSohWYRotational motion of flowering stalk in Spiranthes sinensis and its machineryBiol Sci Space200115325425511997629
   PubMedGoogle Scholar
• SiegmundWLudwigKGiessmannTThe effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinololClin Pharmacol Ther200272557258312426521
   PubMed Web of Science ®Google Scholar
• OzawaSSoyamaASaekiMEthnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1Drug Metab Pharmacokinet2004192839515499174
   PubMedGoogle Scholar
• HaufroidVGenetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug dispositionCurr Drug Targets201112563164621039333
   PubMed Web of Science ®Google Scholar
• CascorbiIGerloffTJohneAFrequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjectsClin Pharmacol Ther200169316917411240981
   PubMed Web of Science ®Google Scholar
• WoodahlELYangZBuiTShenDDHoRJMultidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoproteinJ Pharmacol Exp Ther200431031199120715100388
   PubMed Web of Science ®Google Scholar
• ChangHRhaSYJeungHCAssociation of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patientsAnn Oncol200920227227718836089
   PubMed Web of Science ®Google Scholar
• KafkaASauerGJaegerCPolymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancerInt J Oncol20032251117112112684679
   PubMed Web of Science ®Google Scholar
• KimHJImSAKeamBABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapyCancer Sci20151061869325410489
   PubMed Web of Science ®Google Scholar
• LevyPGligorovJAntoineMInfluence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patientsBreast Cancer Res Treat2013139242142823666532
   PubMed Web of Science ®Google Scholar
• AshariatiAPolymorphism C3435T of the MDR-1 gene predict response to preoperative chemotherapy in locally advanced breast cancer with Her2/neu expressionActa Med Indones200840418719119151448
   PubMedGoogle Scholar
• ZhouZChenQZuoDWangHHuaYCaiZABCB1 (rs1128503) polymorphism and response to chemotherapy in patients with malignant tumors-evidences from a meta-analysisInt J Clin Exp Med20158126527225784996
   PubMed Web of Science ®Google Scholar
• YaoSSuchestonLEZhaoHGermline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancerPharmacogenomics J201414324124723999597
   PubMed Web of Science ®Google Scholar
• VulstekeCPfeilAMSchwenkglenksMImpact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxelBreast Cancer Res Treat2014147355757025168315
   PubMed Web of Science ®Google Scholar
• EckhoffLFeddersenSKnoopASEwertzMBergmannTKDocetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancerActa Oncol201554453053725383449
   PubMed Web of Science ®Google Scholar
• KimKPAhnJHKimSBProspective evaluation of the drug-metabolizing enzyme polymorphisms and toxicity profile of docetaxel in Korean patients with operable lymph node-positive breast cancer receiving adjuvant chemotherapyCancer Chemother Pharmacol20126951221122722271208
   PubMed Web of Science ®Google Scholar
• TranAJullienVAlexandreJPharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphismsClin Pharmacol Ther200679657058016765145
   PubMed Web of Science ®Google Scholar
• SissungTMMrossKSteinbergSMAssociation of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropeniaEur J Cancer200642172893289616950614
   PubMed Web of Science ®Google Scholar
• AbrahamJEGuoQDorlingLReplication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with PaclitaxelClin Cancer Res20142092466247524599932
   PubMed Web of Science ®Google Scholar
• TehLKMohamedNISallehMZThe risk of recurrence in breast cancer patients treated with tamoxifen: polymorphisms of CYP2D6 and ABCB1AAPS J2012141525922183189
   PubMed Web of Science ®Google Scholar
• KimJWKimJHImSAABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapyOncology201283421822722906996
   PubMed Web of Science ®Google Scholar